PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 32817992-4 2020 Results Tacrolimus significantly increased the expression of LIF, IL-10, and IL-17 and decreased the expression of IL-4, IFN-gamma, and the IFN-gamma/IL-10 ratio in RIF patients. Tacrolimus 8-18 interleukin 4 Homo sapiens 115-119 33512727-4 2021 Additionally, we also performed ELISA and Western blot analyses to show that tacrolimus treatment also reduces the levels of eosinophil-specific cytokines IL-4, IL-5, IL-13, TGF-beta, eosinophil-specific chemokines Eotaxin-1, Eotaxin-2, and progenitors target RCAN1 mRNA levels. Tacrolimus 77-87 interleukin 4 Homo sapiens 155-159 32067305-6 2020 Two patients with severe food allergy responded favorably to conversion from tacrolimus-based immunosuppression to MMF and corticosteroids with reduction in clinical symptoms, total IgE, specific IgE, IL-1ra, IL-4, RANTES, PDGF, MIP-1a, and TNFalpha. Tacrolimus 77-87 interleukin 4 Homo sapiens 209-213 28060893-8 2017 Molecular features involved in inflammation and immune response contributing to DN progression were significantly downregulated by tacrolimus (e.g. the tumor necrosis factor alpha (TNF), interleukin 4, or interleukin 10). Tacrolimus 131-141 interleukin 4 Homo sapiens 187-200 32932253-7 2020 The immunological impact of tacrolimus was revealed by reduced percentages of Tfh, Breg, CD19+BAFF-R+ B cells, and increased percentages of Treg cells as well as down-regulated expression of IL-2, IL-4, IL-10, and IL-13 mRNA levels in PBMCs during the treatment. Tacrolimus 28-38 interleukin 4 Homo sapiens 197-201 14767008-5 2004 Although interleukin (IL)-12 production of DC was impaired, they did not promote Th2 development as T cells activated by tacrolimus-treated DC produced less interferon (IFN)-gamma, IL-4 and IL-10. Tacrolimus 121-131 interleukin 4 Homo sapiens 181-185 24836681-3 2014 STUDY DESIGN AND METHODS: DCs derived from human monocytes were induced in vitro by GM-CSF/IL-4 with tacrolimus. Tacrolimus 101-111 interleukin 4 Homo sapiens 91-95 16368244-10 2005 Quantification of intratumor transcription levels using reverse transcription-real-time polymerase chain reaction showed recovery from tacrolimus-induced downregulation of interleukin-4 but not interferon-gamma levels. Tacrolimus 135-145 interleukin 4 Homo sapiens 172-185 9667420-4 1998 FK506-induced apoptosis was efficiently attenuated by co-addition of ILs including IL-1beta (2 ng/ml), IL-2 (5 ng/ml) and IL-4 (40 ng/ml) into culture. Tacrolimus 0-5 interleukin 4 Homo sapiens 122-126 10887335-5 2000 RESULTS: Dexamethasone, FK506, and cyclosporin A suppressed the production of IL-2, IL-4, and IL-5 by human helper T cells, which shows a similar concentration-response relationship in each case. Tacrolimus 24-29 interleukin 4 Homo sapiens 84-88 9510155-8 1998 FK506 also reduced CD3/CD28-induced production of IL-3, IL-4, IL-10, TNF-alpha, and IL-6 but augmented that of GM-CSF, IL-5, IFN-gamma, and IL-13. Tacrolimus 0-5 interleukin 4 Homo sapiens 56-60 11407316-6 2001 In a comparative study with steroids (alclometasone dipropionate and betamethason valerate) in anti-CD3/CD2 system, tacrolimus and both steroids inhibited Th1 cytokines (IL-2, IFN-gamma), Th2 cytokines (IL-4, IL-5) and IL-3, GM-CSF (produced by both Th1 and Th2). Tacrolimus 116-126 interleukin 4 Homo sapiens 203-207 10623799-2 2000 IL-4 mRNA, constitutively present in basophils, was increased after stimulation by gp120 and was inhibited cyclosporin A and tacrolimus. Tacrolimus 125-135 interleukin 4 Homo sapiens 0-4 10515221-11 1999 In conclusion, our study clearly demonstrated that studied ex vivo, FK506 and CsA decrease the frequencies of cells expressing IL-2, IL-4 and IL-2/IFN-gamma in vivo but do not affect those expressing IFN-gamma. Tacrolimus 68-73 interleukin 4 Homo sapiens 133-137 9820545-6 1998 IL-4 mRNA, constitutively present in basophils, was increased after stimulation by pFv and was inhibited by cyclosporin A and tacrolimus. Tacrolimus 126-136 interleukin 4 Homo sapiens 0-4 9667420-6 1998 The data also suggested that cytokine networks including those via IL-1beta and IL-4 in addition to IL-2 prevent FK506-induced apoptosis. Tacrolimus 113-118 interleukin 4 Homo sapiens 80-84 1383612-0 1992 FK-506 inhibits proliferation and IL-4 messenger RNA production by a T-helper 2 cell line. Tacrolimus 0-6 interleukin 4 Homo sapiens 34-38 9469459-8 1998 The immunosuppressant, FK506, while strikingly inhibiting the accumulation of IL-4 mRNA and the secretion of protein in response to IL-3/anti-IgE, had no effect on the generation of IL-13 in these cultures; the resistance was attributed to the IL-3-dependent signaling. Tacrolimus 23-28 interleukin 4 Homo sapiens 78-82 7518925-3 1994 Here, TNF-alpha gene transcription is shown also to be highly and rapidly induced in human B cells after stimulation via the CD40 and interleukin 4 pathways, which similarly is inhibited by CsA and a panel of CsA or FK506 analogues that block calcineurin phosphatase activity. Tacrolimus 216-221 interleukin 4 Homo sapiens 134-147 7507316-6 1993 For instance, CsA and FK 506 inhibit the transcription of IL-3, IL-4, IFN gamma, TNF alpha or GM-CSF by activated T cells, and rapamycin has been shown to block the response to various growth factors such as IL-3, IL-4 or IL-6. Tacrolimus 22-28 interleukin 4 Homo sapiens 64-68 7507316-6 1993 For instance, CsA and FK 506 inhibit the transcription of IL-3, IL-4, IFN gamma, TNF alpha or GM-CSF by activated T cells, and rapamycin has been shown to block the response to various growth factors such as IL-3, IL-4 or IL-6. Tacrolimus 22-28 interleukin 4 Homo sapiens 214-218 1383612-7 1992 FK-506 markedly inhibits Con A-induced proliferation and IL-4 mRNA production by the T-helper 2 cell line Ly1+2-/9. Tacrolimus 0-6 interleukin 4 Homo sapiens 57-61 1383612-8 1992 The ability of FK-506 to block the proliferation and IL-4 production by this helper cell subset suggests that this effect may contribute to its observed marked immunosuppressive properties in vitro and in vivo. Tacrolimus 15-21 interleukin 4 Homo sapiens 53-57 1721312-0 1991 FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line. Tacrolimus 0-6 interleukin 4 Homo sapiens 48-52 1380951-3 1992 While 1 microgram/ml CSA and 0.1 microgram/ml FK 506 completely suppressed PHA-stimulated accumulation of mRNA for IL2, IL4, IL9, GM-CSF, TNF-alpha and IFN-gamma in PBMC, flu, keto and TGF-beta failed to inhibit any (except TNF-alpha blocked by TGF-beta). Tacrolimus 46-52 interleukin 4 Homo sapiens 120-123 1371491-8 1992 When the cells were stimulated by phorbol ester (phorbol 12-myristate 13-acetate, PMA) plus calcium ionophore (ionomycin), FK506 and CsA inhibited, in a dose-dependent manner, the production of IL-2, IL-4, IL-5, IFN-gamma and TNF-alpha. Tacrolimus 123-128 interleukin 4 Homo sapiens 200-204 1384862-7 1992 It is likely that the two drugs inhibit the expression of lymphokine receptors, by interfering Ca(2+)-related signals and that IL-6 induces T cell proliferation in a different way than IL-2 and IL-4, which are FK-506- and Cs A-sensitive. Tacrolimus 210-216 interleukin 4 Homo sapiens 194-198 2472451-1 1989 FK506, a neutral macrolide with immunosuppressive properties, was shown to selectively and rapidly inhibit the accumulation of IL-2 mRNA, as well as the mRNAs of other early (E) phase T cell activation genes such as IL-3, IL-4, GM-CSF, TNF alpha, IFN-gamma, and c-myc in activated human peripheral blood T cells. Tacrolimus 0-5 interleukin 4 Homo sapiens 222-226 1702750-5 1990 FK506 caused a dose-dependent inhibition of cell cycle-related induction of locomotor capacity both of anti-CD3-cultured T cells and IL-4-cultured B cells, with an ID50 of less than 1 ng per ml. Tacrolimus 0-5 interleukin 4 Homo sapiens 133-137